Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults
InfectologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The Journal of infectious diseases
- Publicado em
- 15 set 2025
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan Adults
Nathanial K Copeland, Lucas Otieno, June Doryne Otieno, Solomon Otieno, Salome Chira, Karen Ivinson, Irene Onyango, Ruth Wasuna, Hoseah Akala, Amos Onditi et al.
Descritores MeSH
- Antimalarials
- Plasmodium falciparum
- Malaria, Falciparum
- Malaria Vaccines
- Parasitemia
- Vaccine Efficacy
- Kenya
- Male
- Middle Aged
- Rabies Vaccines
Veja também
Estudos relacionados
- Efficacy and immunogenicity of RTS,S/AS01 and R21/Matrix-M malaria vaccines: - Systematic review and meta-analysis
- Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial
- Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial
- Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine